Amarin reported $3.37M in Interest Income for its fiscal quarter ending in December of 2024.


Interest Income Change Date
AbbVie USD 73M 19M Mar/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Amarin USD 3.37M 3.37M Dec/2024
AstraZeneca 68M 16M Jun/2025
DBV Technologies -0.32 0.02 Sep/2024
GlaxoSmithKline 50M 4M Jun/2025
Ionis Pharmaceuticals -0.66 0.29 Dec/2024